← Back to Clinical Trials
Recruiting NCT06610994

NCT06610994 Acute Effect of Local Vibration in Stroke Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06610994
Status Recruiting
Phase
Sponsor Kırıkkale University
Condition Acute Effect of Local Vibration Application in Stroke Patients
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2025-01-01
Primary Completion 2025-11-01

Trial Parameters

Condition Acute Effect of Local Vibration Application in Stroke Patients
Sponsor Kırıkkale University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 20
Sex ALL
Min Age 45 Years
Max Age 75 Years
Start Date 2025-01-01
Completion 2025-11-01
Interventions
local vibration apply

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The aim of the research is to examine the acute effect of local vibration application on gait and balance in stroke patients.

Eligibility Criteria

Inclusion Criteria: * 45-75 years old diagnosed with stroke * Being diagnosed with ischemic or hemorrhagic stroke, * Not having cooperation and communication problems, * Stroke individuals with gastrosoleus spasticity, those with a MAS score of 2 or below, * Those who score 0-3 on the Modified Rankin Scale. * People weighing less than 150 kilos * Patients who can walk independently (with an assisted device if they use an assistive device) Exclusion Criteria: * Have undergone surgery or botox for spasticity in the last 6 months, * Those with joint contracture, * Having a neurological disease other than stroke that may affect the patient's ability to walk and stand independently, or having pain in the lower extremity joints and a history of fractures in the lower extremities in the last 6 months, * Having spasticity that prevents sole contact * Patients who do not agree to participate in the study and do not give written consent

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology